These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14984475)

  • 21. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary hyperparathyroidism, C-cell hyperplasia and papillary thyroid carcinoma in a patient with RET germline polymorphism S836S.
    Brauckhoff M; Gimm O; Bilkenroth U; Hinze R; Dralle H
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):201-3. PubMed ID: 12410354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.
    Scurini C; Quadro L; Fattoruso O; Verga U; Libroia A; Lupoli G; Cascone E; Marzano L; Paracchi S; Busnardo B; Girelli ME; Bellastella A; Colantuoni V
    Mol Cell Endocrinol; 1998 Feb; 137(1):51-7. PubMed ID: 9607728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 25. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
    Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
    Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
    Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
    Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
    Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
    Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
    J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
    Kitamura Y; Goodfellow PJ; Shimizu K; Nagahama M; Ito K; Kitagawa W; Akasu H; Takami H; Tanaka S; Wells SA
    Oncogene; 1997 Jun; 14(25):3103-6. PubMed ID: 9223675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma.
    Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM
    Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.
    Carlomagno F; Salvatore D; Santoro M; de Franciscis V; Quadro L; Panariello L; Colantuoni V; Fusco A
    Biochem Biophys Res Commun; 1995 Feb; 207(3):1022-8. PubMed ID: 7864888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
    Musholt PB; Musholt TJ; Moley JF; Scheumann GF
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.
    Gimm O; Dziema H; Brown J; Hoang-Vu C; Hinze R; Dralle H; Mulligan LM; Eng C
    Oncogene; 2001 Apr; 20(17):2161-70. PubMed ID: 11360200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
    Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
    J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
    Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
    JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
    Peacock ML; Borst MJ; Sweet JD; Decker RA
    Hum Mutat; 1996; 7(2):100-4. PubMed ID: 8829625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
    Jindrichova S; Kodet R; Krskova L; Vlcek P; Bendlova B
    J Mol Med (Berl); 2003 Dec; 81(12):819-23. PubMed ID: 14618242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
    Acton DS; Velthuyzen D; Lips CJ; Höppener JW
    Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.